Oragenics Inc (OGEN): Total Assets
$10.07M
As of 2025-12-31
$5.49M
As of 2026-06-30
-12.0%
3-year compound annual growth
-11.6%
5-year compound annual growth
+5.7%
10-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $10.07M | +583.7% | 2026-03-16, Balance as of period end |
| 2024-12-31 | $1.47M | -70.4% | 2026-03-16, Balance as of period end |
| 2023-12-31 | $4.97M | -66.3% | 2025-03-14, Balance as of period end |
| 2022-12-31 | $14.76M | -47.7% | 2024-03-29, Balance as of period end |
| 2021-12-31 | $28.23M | +51.1% | 2023-04-17, Balance as of period end |
| 2020-12-31 | $18.68M | -5.4% | 2022-07-29, Balance as of period end |
| 2019-12-31 | $19.75M | -10.4% | 2021-03-01, Balance as of period end |
| 2018-12-31 | $22.05M | +205.6% | 2020-03-04, Balance as of period end |
| 2017-12-31 | $7.21M | +67.4% | 2019-03-29, Balance as of period end |
| 2016-12-31 | $4.31M | -25.4% | 2018-02-16, Balance as of period end |
| 2015-12-31 | $5.78M | -48.1% | 2017-02-27, Balance as of period end |
| 2014-12-31 | $11.13M | -33.9% | 2016-03-30, Balance as of period end |
| 2013-12-31 | $16.83M | +60.5% | 2015-02-27, Balance as of period end |
| 2012-12-31 | $10.49M | +727.8% | 2014-02-28, Balance as of period end |
| 2011-12-31 | $1.27M | -26.7% | 2013-03-26, Balance as of period end |
| 2010-12-31 | $1.73M | n/a | 2012-04-16, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Oragenics Inc (OGEN) | 2025-12-31 | $10.07M | +583.7% |
| Medicus Pharma Ltd. (MDCX) | 2025-12-31 | $10.06M | +78.2% |
| Korsana Biosciences, Inc. (KRSA) | 2025-12-31 | $9.98M | +4.3% |
| Genprex, Inc. (GNPX) | 2025-12-31 | $10.16M | +146.3% |
| Longeveron Inc. (LGVN) | 2025-12-31 | $10.26M | -59.9% |
| Cocrystal Pharma, Inc. (COCP) | 2025-12-31 | $9.71M | -27.8% |
| MAIA Biotechnology, Inc. (MAIA) | 2025-12-31 | $9.70M | -4.4% |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | 2025-12-31 | $10.48M | +318.0% |
| FibroBiologics, Inc. (FBLG) | 2025-12-31 | $9.62M | -41.5% |
Compare OGEN, MDCX, KRSA, GNPX side by side · Screen every company in Pharmaceutical Preparations ↗